DBV Technologies S.A. (DBVT)
NasdaqCM: DBVT
· 即時價格 · USD
14.67
+0.65 (4.64%)
收盤時: Aug 17, 2026, 3:59 PM
DBV Technologies S.A. (DBVT) Stock Price, Analysis & Data
4.64% (1D)
關於DBVT
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy ...
完整的公司簡介獲利驚喜
DBV S.A. 已於 Jul 16, 2026 公布季度財報:
第 1 頁,共 2 頁
